REAL WORLD EVIDENCE (RWE): DIFFERENT NEEDS FOR ONE GOAL
How to address various stakeholder’s perspectives towards the generation of reliable RWE to enhance the value of your product
Real-world evidence should be incorporated throughout all the product’s lifecycle to ensure a significant value during its launch and commercialization. An integrated patient-centric perspective among different stakeholders and a focus on continuous evidence generation is the way forward for the life science industry.
This course will be mainly focused on providing methods to successfully:
- Identify & prioritize the different RWE needs throughout the product lifecycle.
- Apply the observational approach to evaluate “unmet needs” during the clinical development as well as the impact of the drug utilization in the real-world (i.e. patient’s perceptions, effectiveness, safety and benefit in diverse environments and specific patients subset).
- Adopt a multidisciplinary approach to design optimized RWE projects that combine multiple stakeholders needs (i.e. Medical Affairs, Market Access and Clinical Development) to generate clinical evidence aligned with the product strategy and its lifecycle stage.
Date: 29 May 2019
Time: 9:00 am – 6:00 pm
Venue: Copenhagen, Denmark
Cost: Early bird: € 880* (until 02-05-2019)
Ordinary: € 990*
Freelance – Academy – Public Administration: € 460*
* For Italian companies: + 22% VAT
The fee includes: tuition, teaching materials, lunches and coffee breaks, office assistance, attendance certificate
Complete booking and payment at this link and use code MVA1908 to book and receive 15% off.
For any further question feel free to contact Mara Claudia Algarotti email@example.com